Excited that our paper reporting discovery of TMEM55B, a new downstream lysosomal component of the LRRK2 #Parkinsons pathway, has been published. Congrats @Prosen21, @MattTaylor_69, Yuko Lam, & our fantastic @ASAP_Research collaborators @pfeffersuzanne lab https://t.co/saADIvmpt8
Max is an absolutely fantastic driver who has had an incredible season and I have nothing but huge respect for him, but what just happened is absolutely unacceptable. I cannot believe what we’ve just seen.
MRC PPU PhD students advance to the finals of the Biotechnology Young Entrepreneurs Scheme (YES) 2021 https://t.co/gXhi9MAtJU @LeeAArmstrong2 @CartonBill@UoNYES#YES21#Affinitas
Chew the decay away with Affy! Affinitas @dundeeuni new plaque fighting gum uses unique nanobody technology to target the leading cause of plaque formation. #YES21#UnleashYourIngenuity 💚👏
Preprint by Dario Alessi lab @mrcppu in collaboration with GlaxoSmithKline @GSK characterising #LRRK2 Type II inhibitors, revealing these do not induce dephosphorylation of Ser935 biomarker sites https://t.co/KVRObX27yG
Welcome to our Twitter page. We are a Team of 4 groups at @mrcppu and @stanford interested in deciphering the function of the #LRRK2 kinase and its links to #Parkinsons.
Exciting new @biorxivpreprint out from the Ganley Lab in collaboration with @GSK showing that a new #LRRK2 inhibitor can rescue a defect in mitophagy caused by a common #Parkinsons disease mutation https://t.co/ue6ZsO3KpQ
Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms https://t.co/z1pfxbbuwB #bioRxiv
Congratulation to MRC PPU PhD student Matt Taylor, along with the other members of the Dundee Mixed 1st Team, who won the Scottish Conference Cup this week by defeating Aberdeen’s Robert Gordon University at Newburgh-on-Ythan Golf Club by playoff #PhDlife